EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib S Kobayashi, TJ Boggon, T Dayaram, PA Jänne, O Kocher, M Meyerson, ... New England Journal of Medicine 352 (8), 786-792, 2005 | 4855 | 2005 |
Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak M Dai, D Liu, M Liu, F Zhou, G Li, Z Chen, Z Zhang, H You, M Wu, ... Cancer discovery 10 (6), 783-791, 2020 | 1662 | 2020 |
Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species R Zilionis, C Engblom, C Pfirschke, V Savova, D Zemmour, HD Saatcioglu, ... Immunity 50 (5), 1317-1334. e10, 2019 | 1203 | 2019 |
Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein ¥á-deficient mice DE Zhang, P Zhang, N Wang, CJ Hetherington, GJ Darlington, DG Tenen Proceedings of the National Academy of Sciences 94 (2), 569-574, 1997 | 1196 | 1997 |
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-¥á (C/EBP¥á), in acute myeloid leukemia T Pabst, BU Mueller, P Zhang, HS Radomska, S Narravula, S Schnittger, ... Nature genetics 27 (3), 263-270, 2001 | 1162 | 2001 |
Transcription factors, normal myeloid development, and leukemia DG Tenen, R Hromas, JD Licht, DE Zhang Blood, The Journal of the American Society of Hematology 90 (2), 489-519, 1997 | 983 | 1997 |
Disruption of differentiation in human cancer: AML shows the way DG Tenen Nature reviews cancer 3 (2), 89-101, 2003 | 849 | 2003 |
Transcription factors in myeloid development: balancing differentiation with transformation F Rosenbauer, DG Tenen Nature Reviews Immunology 7 (2), 105-117, 2007 | 785 | 2007 |
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP¥á P Zhang, J Iwasaki-Arai, H Iwasaki, ML Fenyus, T Dayaram, BM Owens, ... Immunity 21 (6), 853-863, 2004 | 682 | 2004 |
CCAAT/enhancer binding protein ¥á is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors HS Radomska, CS Huettner, PU Zhang, TAO Cheng, DT Scadden, ... Molecular and cellular biology 18 (7), 4301-4314, 1998 | 668 | 1998 |
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1 F Rosenbauer, K Wagner, JL Kutok, H Iwasaki, MM Le Beau, Y Okuno, ... Nature genetics 36 (6), 624-630, 2004 | 636 | 2004 |
AML1–ETO downregulates the granulocytic differentiation factor C/EBP¥á in t (8; 21) myeloid leukemia T Pabst, BU Mueller, N Harakawa, C Schoch, T Haferlach, G Behre, ... Nature medicine 7 (4), 444-451, 2001 | 610 | 2001 |
Negative cross-talk between hematopoietic regulators: GATA proteins repress PU. 1 P Zhang, G Behre, J Pan, A Iwama, N Wara-Aswapati, HS Radomska, ... Proceedings of the National Academy of Sciences 96 (15), 8705-8710, 1999 | 602 | 1999 |
DNMT1-interacting RNAs block gene-specific DNA methylation A Di Ruscio, AK Ebralidze, T Benoukraf, G Amabile, LA Goff, J Terragni, ... Nature 503 (7476), 371-376, 2013 | 600 | 2013 |
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations DB Costa, B Halmos, A Kumar, ST Schumer, MS Huberman, TJ Boggon, ... PLoS medicine 4 (10), e315, 2007 | 582 | 2007 |
Distinctive and indispensable roles of PU. 1 in maintenance of hematopoietic stem cells and their differentiation H Iwasaki, C Somoza, H Shigematsu, EA Duprez, J Iwasaki-Arai, ... Blood 106 (5), 1590-1600, 2005 | 554 | 2005 |
The macrophage transcription factor PU. 1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor DE Zhang, CJ Hetherington, HM Chen, DG Tenen Molecular and cellular biology 14 (1), 373-381, 1994 | 554 | 1994 |
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma L Chen, Y Li, CH Lin, THM Chan, RKK Chow, Y Song, M Liu, YF Yuan, ... Nature medicine 19 (2), 209-216, 2013 | 546 | 2013 |
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies H Ji, D Li, L Chen, T Shimamura, S Kobayashi, K McNamara, U Mahmood, ... Cancer cell 9 (6), 485-495, 2006 | 542 | 2006 |
Hematopoietic stem cell and multilineage defects generated by constitutive ¥â-catenin activation M Scheller, J Huelsken, F Rosenbauer, MM Taketo, W Birchmeier, ... Nature immunology 7 (10), 1037-1047, 2006 | 529 | 2006 |